Synthesis and dopaminergic properteis of 3- and 4-substituted 1-{-[5-(1H-benzimidazole-2-thione)]ethyl}piperidines and related compounds

Archiv der Pharmazie

Volumn 330, Issue 1-2, 1997, Pages 25-28

  Dukic, Sladjana ^a   Kostic Rajacic, Sladjana ^b   Šoškic, Vukic ^a,b   Joksimovic, Jelena ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Institute for Chemistry   (Yugoslavia)

Author keywords

substituted arylpiperidines, dopaminergic, D1, D2, dopamine receptors

Indexed keywords

1 [2 [5 (1H BENZIMIDAZOLE 2 THIONE)ETHYL] 3 PHENYL]PIPERIDINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; PIPERIDINE DERIVATIVE; UNCLASSIFIED DRUG; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT;

ANIMAL TISSUE; ARTICLE; CATTLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG RECEPTOR BINDING; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; REACTION ANALYSIS; SYNAPTOSOME; ANIMAL; METABOLISM; RADIOASSAY; SYNTHESIS;

ANIMALS; CATTLE; DOPAMINE AGENTS; PIPERIDINES; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2;

EID: 0030610512     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.19973300107     Document Type: Article

References (17)

1. P. Seeman, Trends Pharmacol.Sci. 1994, 15, 264-267.
2. D.M. Jackson, A. Westlind-Danielsson, Pharmac.Ther. 1994, 64, 291-369.
3. H.R. Howard, T.F. Seeger, (1993) In: Annu. Rep. Med. Chem. (Ed.: J.A. Bristol), Academic Press, San Diego, U.S.A, 1993, 28, 39-47.
4. M.D. Tricklebank, L.J. Bristow, P.H. Huston, Prog. Drug Res. 1992, 38, 299-336.
5. Z. Tuce, V. Šoškic, J. Joksimovic. Drug Design Discovery 1994, 11, 251-258.
6. V. Šoškic, A. Maelicke, G. Petrovic, B. Ristic, J. Petrovic, J. Pharm. Pharmacol. 1990, 43, 27-31.
7. L.A. Walters, S.M. McElvain, J. Am. Chem. Soc. 1933, 55, 4625-4629.
8. V. Šoškic, S. Dukic, D. Dragovic, J. Joksimovic, Arzneim.-Forsch.(in press).
9. P.A.J. Janssen U.S. Pat. 3, 161,645, 1964.
10. L.E.J. Kennis, J. Vandenberk, J.C. Martens, U.S. Pat. 4, 533,665, 1985.
11. S. Kostic, V. Šoškic, J. Joksimovic, Arzneim.-Forsch. 1994, 44, 697-702.
12. F. Claudi, G. Giorgioni, A. Di Stefano, M.P. Abbracchio, A.M. Paoletti, W. Balduini, J.Med.Chem. 1992, 35, 4408-4414.
13. H.E. Katerinopoulos, D.I. Schuster, Drugs Future 1987, 12, 223-253.
14. A.S. Horn, In: Comprehensive Medicinal Chemistry (Ed.: C. Hansch), Pergamon Press, New York, 1990, pp. 229-291.
15. M.F. Hibert, A.K. Mir, J.R. Fozard, In: Comprehensive Medicinal Chemistry (Ed.: C. Hansch), Pergamon Press, New York, 1990, pp. 567-601.
16. S. Hjorth, A. Carlsson, D. Clark, K. Svensson, H. Wikström, D. Sanchez, P. Lindberg, U. Hacksell, L.-E, Arvidsson, A. Johansson, J.L.G. Nilsson, Psychopharmacology 1983, 81, 89-99.
17. P.J. Munson, D. Rodbard, Anal.Biochem.1980, 107, 220-239.